OBLN - Obalon Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Obalon Therapeutics, Inc.

5421 Avenida Encinas
Suite F
Carlsbad, CA 92008
United States
760-795-6558
http://www.obalon.com

SectorHealthcare
IndustryMedical Devices
Full Time Employees100

Key Executives

NameTitlePayExercisedYear Born
Mr. Andrew P. RasdalExec. Chairman1.17MN/A1958
Mr. William John Plovanic CFAPres, CEO, Sec. & Director555.95kN/A1969
Dr. Kelly Huang Ph.D.Consultant636.04kN/A1969
Ms. Nooshin HussainyChief Financial OfficerN/AN/A1958
Mr. Mark C. BristerChief Technology OfficerN/AN/A1962
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people who are obese and overweight. The company offers the Obalon balloon system designed to provide weight loss in obese patients. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.

Corporate Governance

Obalon Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.